Möchten Sie immer auf dem neuesten Stand bleiben?

Delray Beach, FL, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Accelerated adoption of AI, wearables, and telehealth platforms is transforming healthcare delivery into a data-driven, patient-centric...

REYKJAVÍK OG LONDON (6. OKTÓBER 2025) - Breska lyfjastofnunin (MHRA) hefur veitt markaðsleyfi fyrir allar útgáfur Gobivaz, hliðstæðu Alvotech við líftæknilyfið Simponi (golimumab). Samstarfsaðili...

REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide...

MOUNTAIN VIEW, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced a new partnership with DRH Health, a full-service regional health system...

TEL AVIV, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative...

SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center...

Imbria Pharmaceuticals announces first patient randomized in Phase 2b FORTITUDE-HCM trial of ninerafaxstat for non-obstructive hypertrophic cardiomyopathy.

WALTHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative therapies for age-related degenerative...

Chemomab announced three presentations "of distinction" at AASLD The Liver Meeting® 2025 featuring clinical data from the nebokitug Phase 2 trial in PSC.

- Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new medicines -  - New Innovative Licensing and Access Pathway (ILAP)...